Identification of Ellagic Acid as Potent Inhibitor of Protein Kinase CK2:  A Successful Example of a Virtual Screening Application

2006 ◽  
Vol 49 (8) ◽  
pp. 2363-2366 ◽  
Author(s):  
Giorgio Cozza ◽  
Paolo Bonvini ◽  
Elisa Zorzi ◽  
Giorgia Poletto ◽  
Mario A. Pagano ◽  
...  
2015 ◽  
Vol 11 (1) ◽  
pp. 21-26 ◽  
Author(s):  
Rashi Srivastava ◽  
◽  
Salman Akthar ◽  
Rolee Sharma ◽  
Sanjay Mishra ◽  
...  

2012 ◽  
Author(s):  
Denis Drygin ◽  
Joshua Bliesath ◽  
Nanni Huser ◽  
Chris Proffitt ◽  
Adam Siddiqui-Jain ◽  
...  

Molecules ◽  
2019 ◽  
Vol 24 (7) ◽  
pp. 1380 ◽  
Author(s):  
Samer Haidar ◽  
Dagmar Aichele ◽  
Robin Birus ◽  
Janine Hielscher ◽  
Tuomo Laitinen ◽  
...  

Protein kinase CK2 is an emerging target for therapeutic intervention in human diseases, particularly in cancer. Inhibitors of this enzyme are currently in clinical trials, indicating the druggability of human CK2. By virtual screening of the ZINC database, we found that the natural compound bikaverin can fit well in the ATP binding site of the target enzyme CK2. By further in vitro evaluation using CK2 holoenzyme, bikaverin turned to be a potent inhibitor with an IC50 value of 1.24 µM. In this work, the cell permeability of bikaverin was determined using a Caco-2 cell permeability assay as a prerequisite for cellular evaluation and the compound turned out to be cell permeable with a Papp- value of 4.46 × 10−6 cm/s. Bikaverin was tested for its effect on cell viability using a MTT assay and cell proliferation using an EdU assay in different cancer cell lines (MCF7, A427 and A431 cells). Cell viability and cell proliferation were reduced dramatically after treatment with 10 µM bikaverin for 24 h. Additionally the IncuCyte® live-cell imaging system was applied for monitoring the cytotoxicity of bikaverin in the three tested cancer cell lines. Finally, molecular dynamic studies were performed to clarify the ligand binding mode of bikaverin at the ATP binding site of CK2 and to identify the amino acids involved.


2015 ◽  
Vol 96 ◽  
pp. 396-404 ◽  
Author(s):  
Isao Nakanishi ◽  
Katsumi Murata ◽  
Naoya Nagata ◽  
Masakuni Kurono ◽  
Takayoshi Kinoshita ◽  
...  

ChemMedChem ◽  
2011 ◽  
Vol 6 (12) ◽  
pp. 2113-2113
Author(s):  
Giorgio Cozza ◽  
Alessandra Gianoncelli ◽  
Paolo Bonvini ◽  
Elisa Zorzi ◽  
Riccardo Pasquale ◽  
...  

2003 ◽  
Vol 306 (1) ◽  
pp. 129-133 ◽  
Author(s):  
Piotr Zień ◽  
Maria Bretner ◽  
Katarzyna Zastąpiło ◽  
Ryszard Szyszka ◽  
David Shugar

Sign in / Sign up

Export Citation Format

Share Document